| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 2,801 | 2,301 | 2,534 | 2,514 | | Selling General and Administrative | 2,263 | 1,572 | 1,527 | 1,809 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,064) | (3,872) | (4,061) | (4,322) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16 | 37 | 72 | 145 | | Earnings Before Interest And Taxes | (5,048) | (3,835) | (3,990) | (4,177) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (5,048) | (3,835) | (3,990) | (4,177) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,048) | (3,835) | (3,990) | (4,177) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,048) | (3,835) | (3,990) | (4,177) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,048) | ($3,835) | ($3,990) | ($4,177) |
|
0.02% Nasdaq 
Income Statement
